Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Field screening and genetic mapping of wheat blast resistance for a panel of common wheat from Bangladesh.

PloS one·2026

Same author

Effect of biopolymers and proteins-based microencapsulation on stability and water solubility of temple waste (Tagetes erecta) derived carotenoids.

Food chemistry·2026

Same author

Atypical Neurological Spectrum of Pediatric Organophosphate Poisoning.

Indian journal of pediatrics·2026

Same author

The Use of Flexible Bronchoscope for Diagnostic Medical Thoracoscopy in a Resource-Limited Setting: A Retrospective Study.

Tanaffos·2026

Same author

Photochemical Synthesis of g-C<sub>3</sub>N<sub>4</sub> Quantum-Dot-Anchored Ag, Pd, and AgPd Alloy Nanoparticles for Catalytic Reduction of 4-Nitrophenol and Antibacterial Activity.

Langmuir : the ACS journal of surfaces and colloids·2026

Same author

Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review.

International journal of molecular sciences·2026

Search research articles

Related Experiment Video

Updated: Jul 17, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Nonsmoker COPD represents a clinically Distinct Phenotype: A Prospective Observational Study.

Richa Rani¹, Pawan K Singh², Manjunath B Govindagoudar²

¹Junior Resident, Department of General Medicine.

The Journal of the Association of Physicians of India

|August 31, 2023

Summary

Chronic obstructive lung disease (COPD) in never-smokers presents earlier with prolonged dyspnea and higher eosinophil counts. Biomass exposure is a key factor in COPD development among non-smokers.

More Related Videos

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Published on: July 12, 2024

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

Related Experiment Videos

Last Updated: Jul 17, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research

Published on: July 12, 2024

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

Area of Science:

Pulmonary Medicine
Respiratory Research

Background:

Chronic obstructive lung disease (COPD) is often misattributed solely to smoking.
Never-smokers constitute a significant portion (nearly 25%) of COPD cases, necessitating further investigation.
Previous studies have largely excluded non-smokers, limiting understanding of COPD in this demographic.

Purpose of the Study:

To investigate the clinical and physiological characteristics of COPD in non-smokers.
To compare COPD presentation and progression between smokers and never-smokers.
To identify risk factors and phenotypic differences in COPD patients who have never smoked.

Main Methods:

Recruited 200 consecutive COPD patients.
Assessed airflow limitation using Global Initiative for COPD (GOLD) 2019 criteria.
Evaluated breathlessness with the modified Medical Research Council (MRC) dyspnea scale.
Collected data on risk factors, clinical history, and biomass exposure.
Analyzed phenotypic differences between smokers and never-smokers.

Main Results:

Never-smokers with COPD presented at a younger age (55.69 years) compared to smokers.
Never-smokers reported a longer duration of dyspnea (7.35 years) than smokers.
Spirometry showed better lung function (FEV1: 47.1%, FVC: 67.38%) in never-smokers versus smokers (FEV1: 40.36%, FVC: 58.16%).
Never-smokers exhibited higher eosinophil counts (232 vs 309) and significantly greater biomass exposure (56.02 vs 6.28).
A higher proportion of never-smokers presented with stage 2 COPD, while smokers predominantly presented with stage 3 COPD.

Conclusions:

COPD in never-smokers is characterized by earlier onset, prolonged dyspnea, and elevated eosinophil counts.
Biomass exposure is identified as a primary etiological factor for COPD in non-smokers.
Findings highlight the distinct clinical profile of COPD in never-smokers, emphasizing the need for tailored diagnostic and treatment approaches.